Giuseppe Cullaro

A kidney-obsessed, learning liver doctor. Lover of the hustle - probably got it from my mama. When I tweet - they’ll be my own.

[Kavish Patidar @KavishPatidar11]

Real-world use of terlipressin for HRS-AKI in the US here.

➡️16-center (n=243 patients)

🔹 Overall Response: 55.1%
🔹 HRS Reversal: 30.9%
🔹 90-day mortality: 40.5%

➡️50% Extended Criteria (presence of ≥1 FDA warning) mostly 2/2 ACLF grade 3.

https://t.co/LTZqBjdTkK

[Giuseppe Cullaro @JoeCullaro]

@bcherny when is bidirectional terminal <-> web coming? would be so helpful as i move between devices.

[Vincenzo Landino @vincenzolandino]

To all new Ferrari fans ‼️

A quick reminder that these little moments of hope during testing could very well be the best moments of our year.

We drink the Holy Hopium. We rejoice in our capable drivers.

For next year is always our year.

Love,
A Ferrari fan for 35+ years

[Giuseppe Cullaro @JoeCullaro]

@howietl Now how to get an invite?!?

[Giuseppe Cullaro @JoeCullaro]

@bcherny Then you realize every app you use on your computer stores everything in a folder.

[Elliot Tapper @ebtapper]

When used wisely albumin can help patients with cirrhosis says the best meta-analysis on this in @HepCommJournal

https://t.co/wKMh5zoXHw

But these trials are small and misuse - SO COMMON - outside of trials is harmful. How to thread the needle?

[Kavish Patidar @KavishPatidar11]

@JoeCullaro

[NYC Transplant Hepatology @NYC_Tx_Hep]

@JoeCullaro , our ⭐️ hepatologist (nephrologist in another life?), presenting his research on cystatin c's role in mortality prediction in patients with cirrhosis #livertwitter #GItwitter #TLM25

[Alyson N. Fox, MD, MSCE @Dr_Aly_Fox]

First Domino Split-Liver Transplant in Adults in the United States https://t.co/EadQZ4rVv4

[Alyson N. Fox, MD, MSCE @Dr_Aly_Fox]

What an amazing day in Teaneck, NJ at the @ColumbiaSurgery @ColumbiaMed Liver Disease Summit!

[Kavish Patidar @KavishPatidar11]

How common is ambulatory AKI (AKI occurring in an outpatient setting) in cirrhosis?

✅It’s common➡️1 in 8
✅Underrecognized➡️42%
✅Key precipitants➡️hypovolemia 2/2 diuretics & GI losses, & nephrotoxin medication exposure
✅Deadly➡️1 in 8 ☠️at 90d

🔥🔥https://t.co/imehINk3wv

[Giuseppe Cullaro @JoeCullaro]

@peduarte Ai chat, dictation that works, Siri that works - centralized place for calendar, email etc, snippets

[Giuseppe Cullaro @JoeCullaro]

@geneyim @ColumbiaMed @NYC_Tx_Hep Thanks, Gene

[HEPATOLOGY Journal @HEP_Journal]

Original Article
The relationship between mean arterial pressure and terlipressin in hepatorenal syndrome-acute kidney injury reversal: a post hoc analysis

Cullaro et al.
#LiverX
https://t.co/4ZWM6z63LX

[Giuseppe Cullaro @JoeCullaro]

https://t.co/2UWvHSfLiy - congrats @KavishPatidar11 - super impactful.

[Kavish Patidar @KavishPatidar11]

What is the relationship btwn terlipressin & MAP

From the genius of @JoeCullaro

https://t.co/wjtcnR9oWR

🔥post-hoc analysis, patient-level data from REVERSE and CONFIRM.

🔥In a time dependent model, 5 mmHg ⬆️ in MAP was associated with 1.17x the hazard of HRS-AKI reversal.

[Giuseppe Cullaro @JoeCullaro]

@raycastapp @raycastapp how do I get in!

[Giuseppe Cullaro @JoeCullaro]

@yuvalpatelMD @KavishPatidar11 @ebtapper Agreed on all fronts, issue is 5L is not the same for all; definitely low MAP predispose to incident AKI, and so added protection in that group seems reasonable.

[Giuseppe Cullaro @JoeCullaro]

@CCHsuMD @AASLDtweets @BlaneyMD @Mironova_MD @DrLoomba I mean who doesn’t want to hear these talks? @ebtapper @BloomPringle @rrosenblattmd @AveshThuluvath #TLM2024

[Christine Hsu, MD @CCHsuMD]

Learn to conduct clinical research with past AASLD presidents, lectures and sit down in round table discussions with Drs. Anna Lok, Vijay Shah, Jorge Marrero, and Gaudalupe Garcia-Tsao Monday at 2pm, 2 sessions! #TLM2024 @AASLDtweets @JoeCullaro @BlaneyMD @Mironova_MD @DrLoomba